Stage
No active trials
Next date
None yet
Trials
0 active
1 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Traumatic Brain Injury
- Main trialPhase 2
- “Brain damage as a result of decreased oxygen to the brain is found in 80% of patients that die with severe head injuries. Laboratory studies in animals and clinical trials have shown that increasing oxygen in the brain results in better brain oxygen consumption, less cell death, and better functional outcome. This study will test the hypothesis that Oxycyte is an effective way to increase brain oxygen levels in severe head injury.”In the company’s words, NCT00174980 on ClinicalTrials.gov
- Other names
- perfluorocarbon
Other drugs for Traumatic Brain Injury
- SovateltidePharmazz, Inc. · Phase 3
- FlornaptitrilCereMark Pharma, LLC · Phase 3
- IncobotulinumtoxinAMerz Pharmaceuticals GmbH · Phase 3
- Autologous HB-adMSCsHope Biosciences LLC · Phase 2
- AbobotulinumtoxinAIpsen · Phase 1/2
- CorabotaseIpsen · Phase 1/2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 2Terminated | Mar 2008 | Study of Oxycyte in Severe Closed Head Injury |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026